Jupiter Asset Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Jupiter Asset Management’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-50,394	Closed	-$527K	–	630
2021 Q4	$527K	Sell	50,394 -10,861	-18%	-$138K	0.01%	467
2021 Q3	$821K	Buy	61,255 +19,966	+48%	+$325K	0.01%	434
2021 Q2	$906K	Buy	+41,289	New	+$917K	0.01%	447

Other funds holding GTHX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Jupiter Asset Management's GTHX Position: Q1 2022 in Review

Jupiter Asset Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2022, closing a stake of 50,394 shares — an estimated $527K sold.

Jupiter Asset Management first reported a position in GTHX in Q2 2021 and held it in 3 quarters. The position peaked at $906K in Q2 2021. 115 funds tracked by Wall St. Rank hold GTHX as of Q1 2022.

Jupiter Asset Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Jupiter Asset Management sold 50,394 G1 Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $527K.
Jupiter Asset Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
Jupiter Asset Management's G1 Therapeutics, Inc. Common Stock position peaked at $906K in Q2 2021.
115 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Jupiter Asset Management's 13F filing for Q1 2022, filed 11 May 2022.